Related references
Note: Only part of the references are listed.The International Collaborative Gaucher Group GRAF (Gaucher Risk Assessment for Fracture) score: a composite risk score for assessing adult fracture risk in imiglucerase-treated Gaucher disease type 1 patients
Patrick Deegan et al.
ORPHANET JOURNAL OF RARE DISEASES (2021)
Are Glucosylceramide-Related Sphingolipids Involved in the Increased Risk for Cancer in Gaucher Disease Patients? Review and Hypotheses
Patricia Dubot et al.
CANCERS (2020)
Real-world effectiveness of eliglustat in treatment-naive and switch patients enrolled in the International Collaborative Gaucher Group Gaucher Registry
Pramod K. Mistry et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
The definition of neuronopathic Gaucher disease
Raphael Schiffmann et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2020)
Osteocyte necrosis triggers osteoclast-mediated bone loss through macrophage-inducible C-type lectin
Darja Andreev et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Eye movement biomarkers allow for the definition of phenotypes in Gaucher Disease
Aimee Donald et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Outcomes after 8 years of eliglustat therapy for Gaucher disease type 1: Final results from the Phase 2 trial
Elena Lukina et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Gaucher Disease in Bone: From Pathophysiology to Practice
Derralynn Hughes et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Height-corrected low bone density associates with severe outcomes in sickle cell disease: SCCRIP cohort study results
Oyebimpe O. Adesina et al.
BLOOD ADVANCES (2019)
Oculomotor and Vestibular Findings in Gaucher Disease Type 3 and Their correlation with Neurological Findings
Tatiana Bremova-Ertl et al.
FRONTIERS IN NEUROLOGY (2018)
Demographics and patient characteristics of 1209 patients with Gaucher disease: Descriptive analysis from the Gaucher Outcome Survey (GOS)
Ari Zimran et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Gaucher disease epidemiology and natural history: a comprehensive review of the literature
Luba Nalysnyk et al.
HEMATOLOGY (2017)
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
Jerome Stirnemann et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Intracellular metabolite β-glucosylceramide is an endogenous Mincle ligand possessing immunostimulatory activity
Masahiro Nagata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Type 3 Gaucher disease, diagnostic in adulthood
Charles Detollenaere et al.
MOLECULAR GENETICS AND METABOLISM REPORTS (2017)
Outcomes after 18 months of eliglustat therapy in treatment-naive adults with Gaucher disease type 1: The phase 3 ENGAGE trial
Pramod K. Mistry et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Eliglustat maintains long-term clinical stability in patients with Gaucher disease type 1 stabilized on enzyme therapy
Timothy M. Cox et al.
BLOOD (2017)
Effect of Oral Eliglustat on Splenomegaly in Patients With Gaucher Disease Type 1 The ENGAGE Randomized Clinical Trial
Pramod K. Mistry et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Consanguinity and founder effect for Gaucher disease mutation G377S in a population from Tabuleiro do Norte, Northeastern Brazil
R. G. Chaves et al.
CLINICAL GENETICS (2015)
Developing novel chemical entities for the treatment of lysosomal storage disorders: an academic perspective
James A. Shayman
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
Abnormal properties of red blood cells suggest a role in the pathophysiology of Gaucher disease
Melanie Franco et al.
BLOOD (2013)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Quantifying the Erlenmeyer flask deformity
A. Carter et al.
BRITISH JOURNAL OF RADIOLOGY (2012)
Deep Phenotyping for Precision Medicine
Peter N. Robinson
HUMAN MUTATION (2012)
Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: A study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry
Aneal Khan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
The French Gaucher's disease registry: clinical characteristics, complications and treatment of 562 patients
Jerome Stirnemann et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
Mapping the genetic and clinical characteristics of Gaucher disease in the Iberian Peninsula
Pilar Giraldo et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
A reappraisal of Gaucher disease-Diagnosis and disease management algorithms
Pramod K. Mistry et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Osteopenia in Gaucher disease develops early in life: Response to imiglucerase enzyme therapy in children, adolescents and adults
Pramod K. Mistry et al.
BLOOD CELLS MOLECULES AND DISEASES (2011)
A monozygotic twin pair with highly discordant Gaucher phenotypes
M. Biegstraaten et al.
BLOOD CELLS MOLECULES AND DISEASES (2011)
Four-year follow-up of chronic neuronopathic Gaucher disease in Europeans using a modified severity scoring tool
Elin Haf Davies et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2011)
Molecular characterization of a new deletion of the GBA1 gene due to an inter Alu recombination event
Monica Cozar et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Osseous Manifestations of Adult Gaucher Disease in the Era of Enzyme Replacement Therapy
Patrick B. Deegan et al.
MEDICINE (2011)
A validated disease severity scoring system for adults with type 1 Gaucher disease
Neal J. Weinreb et al.
GENETICS IN MEDICINE (2010)
Bone density in type 1 gaucher disease
Gregory M. Pastores et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
EyeSeeCam: An Eye Movement-Driven Head Camera for the Examination of Natural Visual Exploration
Erich Schneider et al.
BASIC AND CLINICAL ASPECTS OF VERTIGO AND DIZZINESS (2009)
Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis
Pramod K. Mistry et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
'Non-neuronopathic' Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature
M. Biegstraaten et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2008)
Lysosomal storage disease 1 - Phenotype, diagnosis, and treatment of Gaucher's disease
Gregory A. Grabowski
LANCET (2008)
A severity scoring tool to assess the neurological features of neuronopathic Gaucher disease
E. H. Davies et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
Haemorheology in Gaucher disease
BE Bax et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2005)
Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic
A Zimran et al.
BLOOD CELLS MOLECULES AND DISEASES (2005)
Twin pairs showing discordance of phenotype in adult Gaucher's disease
RH Lachmann et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2004)
Neuropathology provides clues to the pathophysiology of Gaucher disease
KD Wong et al.
MOLECULAR GENETICS AND METABOLISM (2004)
Therapeutic goals in the treatment of Gaucher disease
GM Pastores et al.
SEMINARS IN HEMATOLOGY (2004)
Pulmonary hypertension in type I Gaucher's disease: genetic and epigenetic determinants of phenotype and response to therapy
PK Mistry et al.
MOLECULAR GENETICS AND METABOLISM (2002)
Adaptive modification of saccade amplitude in Parkinson's disease
MR MacAskill et al.
BRAIN (2002)
The Gaucher registry -: Demographics and disease characteristics of 1698 patients with Gaucher disease
J Charrow et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Massive hepatic fibrosis in Gaucher's disease: Clinicopathological and radiological features
RH Lachmann et al.
QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS (2000)
Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis
T Cox et al.
LANCET (2000)
Share Paper
